Sign in

CIK 0001650664

  • Non-accelerated filer
  • Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464097528
Phone
+1 617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
  1. 4 Planned sale SVP, Chief Financial Officer sold 446 shares at $1.72 ($769)
  2. 4 Planned sale EVP, CHIEF SCIENTIFIC OFFICER sold 726 shares at $1.72 ($1,252)
  3. 4 Planned sale CEO sold 15,192 shares at $1.72 ($26,196)
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Planned sale EVP, CHIEF FINANCIAL OFFICER sold 4,109 shares at $1.71 ($7,030)
  10. 4 Planned sale CEO sold 16,632 shares at $1.71 ($28,452)
  11. 4 Planned sale EVP, CHIEF SCIENTIFIC OFFICER sold 2,891 shares at $1.71 ($4,946)
  12. 4 Planned sale CEO sold 1,618 shares at $2.08 ($3,361)
  13. 4 Planned sale EVP, CHIEF MEDICAL OFFICER sold 541 shares at $2.08 ($1,124)
  14. 4 Planned sale EVP, CHIEF MEDICAL OFFICER sold 518 shares at $3.42 ($1,774)
  15. 4 Planned sale CEO sold 1,555 shares at $3.42 ($5,325)
  16. 4 Planned sale EVP, CHIEF SCIENTIFIC OFFICER sold 11,886 shares at $5.42 ($64,370)
  17. 4 Planned sale EVP, CHIEF MEDICAL OFFICER sold 6,619 shares at $5.21 ($34,456)
  18. 4 Planned sale CEO sold 12,191 shares at $5.50 ($66,997)
  19. 4 Planned sale EVP, CHIEF MEDICAL OFFICER sold 511 shares at $5.50 ($2,808)
  20. 4 Derivatives Options or other derivatives

Page 3 of 18 · 351 filings